Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alzheimer's disease
3
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
pfizer
3
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
astrazeneca
biogen
biotech
bristol-myers squibb
cancer
clinical trials
cystic fibrosis
deals
eisai
eli lilly
galapagos nv
What
bio
3
×
drug
roundup
3
×
week
3
×
alzheimer’s
acquisitions
aducanumab
amyloid
angst
annual
assessed
attention
bagged
biggest
billions
biogen
biogen’s
biotech
brammer
build
buy
ceo
communities
company’s
conference
daniel
debut
dyne’s
effects
esmo
europe
failure
felt
germany
gilead
hosted
investment
lost
microbiome
moves
Language
unset
Current search:
bio
×
week
×
roundup
×
pfizer
×
" alzheimer's disease "
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
5 years ago
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More